Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Introducing UNICORN Signals

Powered By EquityPandit
4.5 Google Ratings

Senores Pharmaceuticals Ltd

NSE :SENORES   BSE :544319  Sector : Pharmaceuticals
Buy, Sell or Hold SENORES? Ask The Analyst
Check Gift Nifty (SGX Nifty) Live Price to predict the market.

BSE
Apr 09, 00:00

515.35

-8.45 (-1.61%)

prev close

523.80

OPEN PRICE

516.10

volume

36568

Today's low / high

494.60 / 522.00

52 WK low / high

440.00 / 664.00

bid price (qty)

0 (0)

offer price (qty)

0 (0)

NSE
Apr 09, 00:00

515.65

-7.30 (-1.40%)

prev close

522.95

open price

515.00

volume

536342

Today's' low / high

494.10 / 522.15

52 WK low / high

435.25 / 665.00

bid price (qty)

0 (0)

offer price (qty)

515.65 (12)

09 Apr
515.65
(-1.40%)
08 Apr
522.95
(2.23%)
07 Apr
511.55
(-3.82%)
04 Apr
531.85
(-7.85%)
03 Apr
577.15
(2.86%)
02 Apr
561.10
(-0.51%)
01 Apr
563.95
(-1.17%)
28 Mar
570.60
(-2.86%)
27 Mar
587.40
(1.61%)
26 Mar
578.10
(-2.30%)
25 Mar
591.70
(-5.80%)
24 Mar
628.15
(0.17%)
21 Mar
627.10
(0.82%)
20 Mar
622.00
(-0.13%)
19 Mar
622.80
(0.20%)
18 Mar
621.55
(8.73%)
17 Mar
571.65
(0.87%)
13 Mar
566.70
(-1.64%)
12 Mar
576.15
(4.24%)
11 Mar
552.70
(0.81%)
10 Mar
548.25
(-3.52%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Neutral
Long Term Investors

Bullish

Moving Averages

5 DMA
Bearish

532.09

10 DMA
Bearish

552.52

20 DMA
Bearish

575.17

50 DMA
Bearish

557.06

100 DMA
Bullish

0

200 DMA
Bullish

0


Intraday Support and Resistance
(Based on Pivot Points) NSE : 515.65 | BSE : 515.35

Updated On Apr 09, 2025 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 555.21 538.68 523.36 - -
R2 538.68 527.96 520.79 539.94 -
R1 527.16 521.35 518.22 529.68 532.93
P 510.63 510.63 510.63 511.89 513.51
S1 499.11 499.91 513.08 501.63 504.88
S2 482.58 493.3 510.51 483.84 -
S3 471.06 482.58 507.94 - -

Key Metrics

EPS

0.18

P/E

0

P/B

3.29

Dividend Yield

0%

Market Cap

2,408 Cr.

Face Value

10

Book Value

156.54

ROE

26.19%

EBITDA Growth

29.85 Cr.

Debt/Equity

1.28

Shareholding Pattern

  45.76% Total Promoter Holding
4.99% Mutual Fund Holdings
4.25% FIIs
38.2% Non Institution
3.96% Insurance Companies
0% Custodians
2.84% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Senores Pharmaceuticals Ltd Quaterly Results


Dec 2023Mar 2024Dec 2024
INCOME79.5 104.4 108.18
PROFIT7.1 15.93 17.18
EPS4.01 5.22 5.04

Senores Pharmaceuticals Ltd Quaterly Results


Dec 2023Mar 2024Dec 2024
INCOME11.06 12.16 16.78
PROFIT0.2 0.34 1.07
EPS0.08 0.11 0.32

Profit & Loss (Figures in Rs. Crores)


Senores Pharmaceuticals Ltd Profit & Loss


Mar 2022Mar 2023Mar 2024
INCOME 17.03 39.5 213.46
PROFIT 0.99 8.43 31.48
EPS 0 0 0

Senores Pharmaceuticals Ltd Profit & Loss


Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 8.01 16.88 19.65 41.25
PROFIT 0.84 0.68 1.2 0.81
EPS 2.2 0.78 1.22 0.27

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022
SOURCES OF FUNDS :
Share Capital 30.519.828.74
Reserves Total 173.7635.6827.85
Total Shareholders Funds204.2745.536.59
Minority Interest27.4400
Secured Loans 81.053.161.99
Unsecured Loans 176.659.4412.76
Total Debt257.6562.614.75
Other Liabilities1.240.260.05
Total Liabilities490.6108.3651.39
APPLICATION OF FUNDS :
Gross Block 248.530.38.17
Less: Accumulated Depreciation13.083.061.28
Net Block235.4227.246.89
Capital Work in Progress97.0834.468.06
Investments 0.0116.4515.41
Inventories 37.373.122.98
Sundry Debtors 112.0122.1119.63
Cash and Bank Balance13.060.13.22
Loans and Advances 88.4726.011.22
Total Current Assets250.9151.3427.05
Current Liabilities 122.818.947.62
Provisions 8.491.670.14
Total Current Liabilities & Provisions131.2920.67.75
Net Current Assets119.6230.7419.3
Deferred Tax Assets14.960.170.45
Deferred Tax Liability02.270
Net Deferred Tax14.96-2.10.45
Other Assets23.51.561.29
Total Assets490.6108.3651.41
Contingent Liabilities39.938.350
Mar 2024Mar 2023Mar 2022Mar 2021
SOURCES OF FUNDS :
Share Capital 30.519.828.743.8
Reserves Total 137.6129.1124.955.67
Total Shareholders Funds168.1238.9333.699.47
Secured Loans 14.583.011.990.49
Unsecured Loans 79.5457.6512.763.22
Total Debt94.1260.6614.753.71
Other Liabilities7.221.840.050
Total Liabilities269.46101.4348.4913.18
APPLICATION OF FUNDS :
Gross Block 26.088.292.872.26
Less : Accumulated Depreciation 20.521.280.57
Net Block 24.087.771.591.69
Capital Work in Progress18.4711.333.172.71
Investments 81.588.2311.691.45
Inventories 4.523.122.980.34
Sundry Debtors 22.0115.738.370.23
Cash and Bank Balance10.440.091.411.64
Loans and Advances 2.988.741.225.98
Total Current Assets39.9527.6813.988.19
Current Liabilities 15.29.756.531.58
Provisions 1.20.550.140.2
Total Current Liabilities & Provisions16.4110.36.671.79
Net Current Assets23.5517.387.316.41
Deferred Tax Assets0.210.180.450.77
Net Deferred Tax0.210.180.450.77
Other Assets121.5656.5324.280.14
Total Assets269.46101.4248.4913.18
Contingent Liabilities000.130.13

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...24.94
Depreciation10.02
Interest (Net)8.04
Prov. and W/O (Net)-0.03
P/L in Forex-0.25
Others-1.36
Total Adjustments (PBT and Ext...17.86
Operating Profit before Workin...42.8
Trade and 0ther Receivables-57.11
Inventories-1.04
Trade Payables50.9
Loans and Advances0.42
Total Adjustments (OP before W...-54.67
Cash Generated from/(used in) ...-11.87
Direct Taxes Paid-8.01
Total Adjustments(Cash Generat...-8.01
Cash Flow before Extraordinary...-19.87
Net Cash from Operating Activi...-19.87
Purchased of Fixed Assets-51.83
Interest Received0.46
Acquisition of Companies-3.29
Net Cash used in Investing Act...-54.16
Proceeds from Issue of shares ...36.99
Proceed from 0ther Long Term B...3.17
Proceed from Short Tem Borrowi...58.04
Of Financial Liabilities-1.37
Interest Paid-8.5
Net Cash used in Financing Act...86.98
Net Profit before Tax and Extr...2.04
Depreciation2.04
Interest (Net)2.55
Total Adjustments (PBT and Ext...3.16
Operating Profit before Workin...5.2
Trade and 0ther Receivables-6.29
Inventories-1.39
Trade Payables7.24
Total Adjustments (OP before W...-61.07
Cash Generated from/(used in) ...-55.87
Interest Paid(Net)-5.75
Direct Taxes Paid-1.19
Total Adjustments(Cash Generat...-6.94
Cash Flow before Extraordinary...-62.82
Net Cash from Operating Activi...-62.82
Purchased of Fixed Assets-19.26
Interest Received5.75
Net Cash used in Investing Act...-13.51
Proceeds from Issue of shares ...5.87
Proceed from Issue of Debentur...31.12
Proceed from 0ther Long Term B...52.35
Of Financial Liabilities-0.13
Interest Paid-2.55
Net Cash used in Financing Act...86.68

Company Details

Registered Office
Address#.1101-1103 11th Flr South Twr,
Ambali Bopal Road
CityAhmedabad
StateGujarat
Pin Code380054
Tel. No.+91-79-2999 9857
Fax. No.
Emailcs@senorespharma.com
Internethttp://www.senorespharma.com
Registrars
Address#.1101-1103 11th Flr South Twr
CityAhmedabad
StateGujarat
Pin Code380054
Tel. No.+91-79-2999 9857
Fax. No.
Emailcs@senorespharma.com
Internethttp://www.senorespharma.com
Management
Name Designation
SWAPNIL JATINBHAI SHAHManaging Director
Sanjay MajmudarChairman (Non-Executive)
Hemanshu Nitinchandra PandyaNon Executive Director
Jitendra Babulal SanghviIndependent Director
Chetan Bipinchandra ShahWhole Time Director & COO
Deval Rajnikant ShahWhole Time Director & CFO
Ashokkumar Vijaysinh BarotNon Executive Director
ARPIT DEEPAKKUMAR SHAHNon Executive Director
Naresh Bansilal ShahIndependent Director
Manjula Devi ShroffIndependent Director
Kalpit Rajesh GandhiIndependent Director
Udayan ChoksiIndependent Director
Nidhi Dilipbhai KapadiaCompany Sec. & Compli. Officer